Viewing Study NCT02358356

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2026-02-22 @ 7:02 AM
Study NCT ID: NCT02358356
Status: COMPLETED
Last Update Posted: 2022-07-05
First Post: 2014-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study
Sponsor: Australasian Gastro-Intestinal Trials Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Midgut Neuroendocrine Tumours View
None Pancreatic Neuroendocrine Tumours View
Keywords:

Keywords

Keyword Brief Keyword Text View
None midgut View
None pancreatic View
None neuroendocrine View
None advanced View
None unresectable low View
None intermediate grade View
None mNETs View
None pNETs View